BMAL1 and depressive disorder: In summary, animal studies have elucidated that BMAL1 is involved in the pathogenesis of mood disorders (mostly depression- and anxiety-like phenotypes) through dysregulation of hormonal axes, including the HPA, inflammation, and neurotransmitter systems.